| [1] |
de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol, 2011, 29(23):3140-3145.
|
| [2] |
Ribero D, Pinna AD, Guglielmi A, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients[J]. Arch Surg, 2012, 147(12):1107-1113.
|
| [3] |
Ransome E, Tong L, Espinosa J, et al. Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005-2014[J]. J Gastrointest Oncol, 2019, 10(2): 339-347.
|
| [4] |
Shen WF, Zhong W, Xu F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma[J]. World J Gastroenterol, 2009, 15(47):5976-5982.
|
| [5] |
Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2015, 22(12):4020-4028.
|
| [6] |
Weber SM, Ribero D, O'Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement[J]. HPB, 2015, 17(8):669-680.
|
| [7] |
Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis[J]. J Surg Oncol, 2017, 116(2):133-139.
|
| [8] |
Sapisochin G, Fernandez de Sevilla E, Echeverri J, et al. Liver transplantation for cholangiocarcinoma: current status and new insights[J]. World J Hepatol, 2015, 7(22):2396-2403.
|
| [9] |
Goydos JS, Brumfield AM, Frezza E, et al. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker[J]. Ann Surg, 1998, 227(3):398-404.
|
| [10] |
Miura JT, Johnston FM, Tsai S, et al. Chemotherapy for surgically resected intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2015, 22(11):3716-3723.
|
| [11] |
Kim YS, Oh SY, Go SI, et al. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas[J]. Cancer Chemother Pharmacol, 2017, 79(1): 99-106.
|
| [12] |
Sahai V, Catalano PJ, Zalupski MM, et al. Nab-paclitaxel and gemcitabine as first-line treatment of advanced or metastatic cholangiocarcinoma: a phase 2 clinical trial[J]. JAMA Oncol, 2018, 4(12):1707-1712.
|
| [13] |
Konstantinidis IT, Groot Koerkamp B, Do RK, et al. Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone[J]. Cancer, 2016, 122(5):758-765.
|
| [14] |
Kim JH, Yoon HK, Sung KB, et al. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes[J]. Cancer, 2008, 113(7):1614-1622.
|
| [15] |
Han K, Ko HK, Kim KW, et al. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. J Vasc Interv Radiol, 2015, 26(7):943-948.
|
| [16] |
Ohkawa A, Mizumoto M, Ishikawa H, et al. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2015, 30(5):957-963.
|
| [17] |
Zhu AX, Borger DR, Kim Y, et al. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets[J]. Ann Surg Oncol, 2014, 21(12):3827-3834.
|
| [18] |
Valle JW, Wasan H, Lopes A, et al. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial[J]. Lancet Oncol, 2015, 16(8):967-978.
|
| [19] |
Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24(3): 1073274817729241.
|
| [20] |
Sicklick JK, Leyland-Jones B, Kato S, et al. Abstract CT053: high rates of personalized molecular matching are achievable ina precision oncology navigation trial: the I-PREDICT study[J]. Cancer Research, 2017, DOI: 10.1158/1538-7445.AM2017-CT053. |